scispace - formally typeset
Search or ask a question
Institution

Wellcome Trust Sanger Institute

NonprofitCambridge, United Kingdom
About: Wellcome Trust Sanger Institute is a nonprofit organization based out in Cambridge, United Kingdom. It is known for research contribution in the topics: Population & Genome. The organization has 4009 authors who have published 9671 publications receiving 1224479 citations.


Papers
More filters
Journal ArticleDOI
Dajiang J. Liu1, Gina M. Peloso2, Gina M. Peloso3, Haojie Yu4  +285 moreInstitutions (91)
TL;DR: It is found that beta-thalassemia trait carriers displayed lower TC and were protected from coronary artery disease (CAD), and only some mechanisms of lowering LDL-C appeared to increase risk for type 2 diabetes (T2D); and TG-lowering alleles involved in hepatic production of TG-rich lipoproteins tracked with higher liver fat, higher risk for T2D, and lower risk for CAD.
Abstract: We screened variants on an exome-focused genotyping array in >300,000 participants (replication in >280,000 participants) and identified 444 independent variants in 250 loci significantly associated with total cholesterol (TC), high-density-lipoprotein cholesterol (HDL-C), low-density-lipoprotein cholesterol (LDL-C), and/or triglycerides (TG). At two loci (JAK2 and A1CF), experimental analysis in mice showed lipid changes consistent with the human data. We also found that: (i) beta-thalassemia trait carriers displayed lower TC and were protected from coronary artery disease (CAD); (ii) excluding the CETP locus, there was not a predictable relationship between plasma HDL-C and risk for age-related macular degeneration; (iii) only some mechanisms of lowering LDL-C appeared to increase risk for type 2 diabetes (T2D); and (iv) TG-lowering alleles involved in hepatic production of TG-rich lipoproteins (TM6SF2 and PNPLA3) tracked with higher liver fat, higher risk for T2D, and lower risk for CAD, whereas TG-lowering alleles involved in peripheral lipolysis (LPL and ANGPTL4) had no effect on liver fat but decreased risks for both T2D and CAD.

465 citations

Journal ArticleDOI
24 Apr 2014-Nature
TL;DR: It is shown that the Izumo1–Juno interaction is conserved within several mammalian species, including humans, and it is proposed to rename it Juno to provide opportunities for the rational development of new fertility treatments and contraceptives.
Abstract: Fertilization occurs when sperm and egg recognize each other and fuse to form a new, genetically distinct organism. The molecular basis of sperm-egg recognition is unknown, but is likely to require interactions between receptor proteins displayed on their surface. Izumo1 is an essential sperm cell-surface protein, but its receptor on the egg has not been described. Here we identify folate receptor 4 (Folr4) as the receptor for Izumo1 on the mouse egg, and propose to rename it Juno. We show that the Izumo1-Juno interaction is conserved within several mammalian species, including humans. Female mice lacking Juno are infertile and Juno-deficient eggs do not fuse with normal sperm. Rapid shedding of Juno from the oolemma after fertilization suggests a mechanism for the membrane block to polyspermy, ensuring eggs normally fuse with just a single sperm. Our discovery of an essential receptor pair at the nexus of conception provides opportunities for the rational development of new fertility treatments and contraceptives.

464 citations

Journal ArticleDOI
Abbas Dehghan1, Josée Dupuis2, Josée Dupuis3, Maja Barbalić4, Joshua C. Bis5, Gudny Eiriksdottir, Chen Lu2, Niina Pellikka, Henri Wallaschofski6, Johannes Kettunen7, Peter Henneman8, Jens Baumert, David P. Strachan9, Christian Fuchsberger, Veronique Vitart10, James F. Wilson10, Guillaume Paré11, Silvia Naitza, Megan E. Rudock12, Ida Surakka13, Eco J. C. de Geus14, Behrooz Z. Alizadeh, Jack M. Guralnik3, Alan R. Shuldiner, Toshiko Tanaka, Robert Y.L. Zee11, Renate B. Schnabel15, Vijay Nambi16, Maryam Kavousi1, Samuli Ripatti13, Matthias Nauck6, Nicholas L. Smith5, Albert V. Smith, Jouko Sundvall, Paul Scheet17, Yongmei Liu12, Aimo Ruokonen18, Lynda M. Rose11, Martin G. Larson2, Martin G. Larson3, Ron C. Hoogeveen16, Nelson B. Freimer11, Alexander Teumer, Russell P. Tracy, Lenore J. Launer3, Julie E. Buring11, Jennifer F. Yamamoto2, Jennifer F. Yamamoto3, Aaron R. Folsom19, Eric J.G. Sijbrands1, James S. Pankow19, Paul Elliott20, John F. Keaney2, John F. Keaney3, Wei Sun21, Antti-Pekka Sarin13, João D. Fontes3, João D. Fontes2, Sunita Badola, Brad C. Astor16, Albert Hofman1, Anneli Pouta, Karl Werdan22, Karin Halina Greiser22, Karin Halina Greiser23, Oliver Kuss22, Henriette E. Meyer zu Schwabedissen, Joachim Thiery24, Yalda Jamshidi25, Yalda Jamshidi9, Ilja M. Nolte, Nicole Soranzo7, Tim D. Spector9, Henry Völzke, Alex Parker26, Thor Aspelund27, David W. Bates11, Lauren Young26, Kim Tsui26, David S. Siscovick5, Xiuqing Guo28, Jerome I. Rotter28, Manuela Uda, David Schlessinger, Igor Rudan29, Igor Rudan10, Andrew A. Hicks, Brenda W.J.H. Penninx14, Barbara Thorand, Christian Gieger, Joe Coresh16, Gonneke Willemsen14, Tamara B. Harris3, André G. Uitterlinden1, Marjo-Riitta Järvelin, Kenneth Rice5, Dörte Radke, Veikko Salomaa, Ko Willems van Dijk8, Eric Boerwinkle4, Ramachandran S. Vasan, Luigi Ferrucci, Quince Gibson, Stefania Bandinelli, Harold Snieder, Dorret I. Boomsma14, Xiangjun Xiao17, Harry Campbell10, Caroline Hayward10, Peter P. Pramstaller, Cornelia M. van Duijn1, Leena Peltonen7, Bruce M. Psaty, Vilmundur Gudnason27, Paul M. Ridker11, Georg Homuth, Wolfgang Koenig30, Christie M. Ballantyne16, Jacqueline C.M. Witteman1, Emelia J. Benjamin, Markus Perola, Daniel I. Chasman11 
TL;DR: A genome-wide association analysis of CRP identified 18 loci that were associated with CRP levels and highlighted immune response and metabolic regulatory pathways involved in the regulation of chronic inflammation.
Abstract: Background—C-reactive protein (CRP) is a heritable marker of chronic inflammation that is strongly associated with cardiovascular disease. We sought to identify genetic variants that are associated with CRP levels. Methods and Results—We performed a genome-wide association analysis of CRP in 66 185 participants from 15 population-based studies. We sought replication for the genome-wide significant and suggestive loci in a replication panel comprising 16 540 individuals from 10 independent studies. We found 18 genome-wide significant loci, and we provided evidence of replication for 8 of them. Our results confirm 7 previously known loci and introduce 11 novel loci that are implicated in pathways related to the metabolic syndrome (APOC1, HNF1A, LEPR, GCKR, HNF4A, and PTPN2) or the immune system (CRP, IL6R, NLRP3, IL1F10, and IRF1) or that reside in regions previously not known to play a role in chronic inflammation (PPP1R3B, SALL1, PABPC4, ASCL1, RORA, and BCL7B). We found a significant interaction of body ...

463 citations

Journal ArticleDOI
TL;DR: The postsynaptic density from human neocortex (hPSD) was isolated and 1,461 proteins were identified that were enriched in cognitive, affective and motor phenotypes underpinned by sets of genes.
Abstract: We isolated the postsynaptic density from human neocortex (hPSD) and identified 1,461 proteins. hPSD mutations cause 133 neurological and psychiatric diseases and were enriched in cognitive, affective and motor phenotypes underpinned by sets of genes. Strong protein sequence conservation in mammalian lineages, particularly in hub proteins, indicates conserved function and organization in primate and rodent models. The hPSD is an important structure for nervous system disease and behavior.

462 citations

Journal ArticleDOI
15 Jun 2017-Nature
TL;DR: This study outlines the major sources of genetic and phenotypic variation in iPS cells and establishes their suitability as models of complex human traits and cancer.
Abstract: Technology utilizing human induced pluripotent stem cells (iPS cells) has enormous potential to provide improved cellular models of human disease. However, variable genetic and phenotypic characterization of many existing iPS cell lines limits their potential use for research and therapy. Here we describe the systematic generation, genotyping and phenotyping of 711 iPS cell lines derived from 301 healthy individuals by the Human Induced Pluripotent Stem Cells Initiative. Our study outlines the major sources of genetic and phenotypic variation in iPS cells and establishes their suitability as models of complex human traits and cancer. Through genome-wide profiling we find that 5-46% of the variation in different iPS cell phenotypes, including differentiation capacity and cellular morphology, arises from differences between individuals. Additionally, we assess the phenotypic consequences of genomic copy-number alterations that are repeatedly observed in iPS cells. In addition, we present a comprehensive map of common regulatory variants affecting the transcriptome of human pluripotent cells.

462 citations


Authors

Showing all 4058 results

NameH-indexPapersCitations
Nicholas J. Wareham2121657204896
Gonçalo R. Abecasis179595230323
Panos Deloukas162410154018
Michael R. Stratton161443142586
David W. Johnson1602714140778
Michael John Owen1601110135795
Naveed Sattar1551326116368
Robert E. W. Hancock15277588481
Julian Parkhill149759104736
Nilesh J. Samani149779113545
Michael Conlon O'Donovan142736118857
Jian Yang1421818111166
Christof Koch141712105221
Andrew G. Clark140823123333
Stylianos E. Antonarakis13874693605
Network Information
Related Institutions (5)
Broad Institute
11.6K papers, 1.5M citations

96% related

Howard Hughes Medical Institute
34.6K papers, 5.2M citations

95% related

Laboratory of Molecular Biology
24.2K papers, 2.1M citations

94% related

Salk Institute for Biological Studies
13.1K papers, 1.6M citations

93% related

National Institutes of Health
297.8K papers, 21.3M citations

93% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202317
202270
2021836
2020810
2019854
2018764